Literatura académica sobre el tema "FBXO24"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "FBXO24".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "FBXO24"
Chen, Wei, Sheng Xiong, Jin Li, Xiuying Li, Yuan Liu, Chunbin Zou y Rama K. Mallampalli. "The Ubiquitin E3 Ligase SCF-FBXO24 Recognizes Deacetylated Nucleoside Diphosphate Kinase A To Enhance Its Degradation". Molecular and Cellular Biology 35, n.º 6 (12 de enero de 2015): 1001–13. http://dx.doi.org/10.1128/mcb.01185-14.
Texto completoYuan, Lamei, Zhi Song, Xiong Deng, Zhijian Yang, Yan Yang, Yi Guo, Hongwei Lu y Hao Deng. "Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson’s Disease". Neuroscience Bulletin 33, n.º 5 (24 de marzo de 2017): 510–14. http://dx.doi.org/10.1007/s12264-017-0122-5.
Texto completoChen, Wei, Denghui Gao, Long Xie, Anling Wang, Hui Zhao, Chaowan Guo, Yunqi Sun, Yanfeng Nie, An Hong y Sheng Xiong. "SCF-FBXO24 regulates cell proliferation by mediating ubiquitination and degradation of PRMT6". Biochemical and Biophysical Research Communications 530, n.º 1 (septiembre de 2020): 75–81. http://dx.doi.org/10.1016/j.bbrc.2020.06.007.
Texto completoZhang, Yuan-Meng, Ling-Bing Meng, Si-Jun Yu y Dong-Xing Ma. "Identification of potential crucial genes in monocytes for atherosclerosis using bioinformatics analysis". Journal of International Medical Research 48, n.º 4 (abril de 2020): 030006052090927. http://dx.doi.org/10.1177/0300060520909277.
Texto completoAngeli, Franca, Russell Wyborski, Bill Chen, Rama Mallampalli y Michael Lark. "P157 FBXO3-FBXL2 AXIS MODULATORS AS A NOVEL CLASS OF ORAL SMALL MOLECULE COMPOUNDS FOR THE TREATMENT OF CROHN’S DISEASE". Inflammatory Bowel Diseases 26, Supplement_1 (enero de 2020): S6. http://dx.doi.org/10.1093/ibd/zaa010.014.
Texto completoMasle-Farquhar, Etienne, Amanda Russell, Yangguang Li, Fen Zhu, Lixin Rui, Robert Brink y Christopher C. Goodnow. "Loss-of-function of Fbxo10, encoding a post-translational regulator of BCL2 in lymphomas, has no discernible effect on BCL2 or B lymphocyte accumulation in mice". PLOS ONE 16, n.º 4 (29 de abril de 2021): e0237830. http://dx.doi.org/10.1371/journal.pone.0237830.
Texto completoManfiolli, Adriana O., Ana Leticia G. C. Maragno, Munira M. A. Baqui, Sami Yokoo, Felipe R. Teixeira, Eduardo B. Oliveira y Marcelo D. Gomes. "FBXO25-associated Nuclear Domains: A Novel Subnuclear Structure". Molecular Biology of the Cell 19, n.º 5 (mayo de 2008): 1848–61. http://dx.doi.org/10.1091/mbc.e07-08-0815.
Texto completoGuo, Fengjie, Xiaoyu Jiang, Domenico Roberti, Lixin Rui y Izidore S. Lossos. "FBXO10 Targets HGAL for Degradation". Blood 126, n.º 23 (3 de diciembre de 2015): 3904. http://dx.doi.org/10.1182/blood.v126.23.3904.3904.
Texto completoQie, Shuo. "The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives". Cancers 14, n.º 9 (25 de abril de 2022): 2133. http://dx.doi.org/10.3390/cancers14092133.
Texto completoQie, Shuo. "The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives". Cancers 14, n.º 9 (25 de abril de 2022): 2133. http://dx.doi.org/10.3390/cancers14092133.
Texto completoTesis sobre el tema "FBXO24"
Medeiros, Ana Carla. "Caracterização parcial do complexo SCF1 contendo a proteína FBXO25 fosforilada". Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/17/17131/tde-09092015-110529/.
Texto completoThe FBXO25 is an E3 ligase RING type (Really Interesting New Gene), SCF oligomeric type, responsible for the specific recognition of the substrate to be degraded via the ubiquitin-proteasome system (SUP). SUP is the main intracellular proteolytic mechanism responsible for 80-90% degradation of cytosolic and nuclear proteins. The FBXO25 is capable of forming a complex SCF1 (formed by the interaction of proteins Skp1, Cul1, Roc1 protein and a type F-box), resulting in an active SCF complex which is able to ubiquitinate their substrates. This protein accumulates in the nucleus forming a subnuclear structure called FANDs (FBXO25 Associated Nuclear Domains) that are involved in nuclear ubiquitination. In this work, we purify complex SCF1 (WT or F- box, which is not able to interact with Skp1), treated or not with PMA, by immunoprecipitation technique. We identified by mass spectrometry, an essential phosphorylation site for FBXO25, when it is phosphorylated under the action of the mitogenic reagent PMA. We also search for differentially ubiquitinated substrates for these complexes, by testing in ProtoArrays® identifying substrates involved in the signaling pathway ERK1 / 2.
Vieira, Nichelle Antunes. "Caracterização de células humanas Hap1 nocaute para FBXO25: via de sinalização da ERK quinase e proliferação celular". Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/17/17131/tde-25042018-143544/.
Texto completoThe FBXO25 protein is an SCF-type E3-ligase responsible for the selectivity of Ub binding to the protein and the targeting of the labeled protein to the 26s proteasome barrel. FBXO25 has been long known to be able to interact and ubiquitinate the Elk-1 protein in HEK293T cells, thereby inducing a decrease in the expression of important genes in the regulation of cell proliferation such as CFOS and EGR-1 after stimulation with the mitogen PMA. Here we show that FBXO25 acts at another point in the MAPK pathway by modulating the ERK1/2 phosphorylation levels. We observed that the treatment with PMA rised the phosphorylated levels of ERK1/2 in knockout cells for FBXO25 (FBXO25KO) when compared to its parental lineage. Stimulation with the mitogens PMA or ATP also led to an increase in cell proliferation unrelated to a direct modulation of the cell cycle in knockout cells, with a significant weight of apoptosis levels being observed. Taking these results together, we show that FBXO25 acts on MAPK signaling by reducing ERK1/2 activation and thus promotes a secondary response on the cell proliferation phenotype.
Tsui, Hoyee. "The role of p21-activated kinase 1 (Pak1) in the heart". Thesis, University of Manchester, 2015. https://www.research.manchester.ac.uk/portal/en/theses/the-role-of-p21activated-kinase-1-pak1-in-the-heart(8c34d7bc-a2aa-4ae0-a197-91ed905212f5).html.
Texto completoStavropoulou, Alexandra Vassiliki. "Histone deacetylase (HDAC) inhibitors and FBXL20 in breast cancer". Thesis, Imperial College London, 2008. http://hdl.handle.net/10044/1/7389.
Texto completoPatel, Shachi. "Fbxo7 in T cell development and oncogenesis". Thesis, University of Cambridge, 2015. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709293.
Texto completoRowicka, Paulina Aiko. "The role of FBXO7 in mitochondrial biology and Parkinson's disease". Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/282989.
Texto completoSammler, Esther. "Signalling pathway of FBXO7 and its role in hereditary Parkinsonism". Thesis, University of Dundee, 2014. https://discovery.dundee.ac.uk/en/studentTheses/2a2889b3-20b5-4353-af11-72782c07ef3a.
Texto completoLiu, Jia y 劉佳. "Role of FBXO31 in regulating MAPK-mediated genotoxic stress response and cancer cell survival". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/205657.
Texto completopublished_or_final_version
Anatomy
Doctoral
Doctor of Philosophy
Kleppa, Marc-Jens [Verfasser]. "Charakterisierung des Gens Fbxl22 und seiner Funktion während der Muskelentwicklung der Maus / Marc-Jens Kleppa". Hannover : Technische Informationsbibliothek und Universitätsbibliothek Hannover (TIB), 2011. http://d-nb.info/1019235071/34.
Texto completoShang, Jinsai. "STRUCTURAL AND FUNCTIONAL STUDIES OF F-BOX-ONLY PROTEIN FBXO7 AND ITS INTERACTIONS WITH PROTEASOME INHIBITOR PI31". OpenSIUC, 2015. https://opensiuc.lib.siu.edu/dissertations/1053.
Texto completoLibros sobre el tema "FBXO24"
Haydu, Julie Erika M. The Roles of F-box and Leucine-Rich Repeat Protein 4 (FBXL4) in Mitochondrial Encephalopathy and T-cell Acute Lymphoblastic Leukemia. [New York, N.Y.?]: [publisher not identified], 2015.
Buscar texto completoCapítulos de libros sobre el tema "FBXO24"
Morton, Sarah U., Edward G. Neilan, Roy W. A. Peake, Jiahai Shi, Klaus Schmitz-Abe, Meghan Towne, Kyriacos Markianos, Sanjay P. Prabhu y Pankaj B. Agrawal. "Hyperammonemia as a Presenting Feature in Two Siblings with FBXL4 Variants". En JIMD Reports, 7–15. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/8904_2016_17.
Texto completoAntoun, Ghadi, Skye McBride, Jason R. Vanstone, Turaya Naas, Jean Michaud, Stephanie Redpath, Hugh J. McMillan et al. "Detailed Biochemical and Bioenergetic Characterization of FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion". En JIMD Reports, 1–9. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/8904_2015_491.
Texto completoGuo, Jianping, Brian J. North, Adriana E. Tron, Hiroyuki Inuzuka y Wenyi Wei. "The Role of FBXO Subfamily of F-box Proteins in Tumorigenesis". En SCF and APC E3 Ubiquitin Ligases in Tumorigenesis, 73–87. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-05026-3_4.
Texto completoActas de conferencias sobre el tema "FBXO24"
Ravindranath, Abhilash K., Swayamjot Kaur y Lorna Rodriguez. "Abstract 4226: CD44 increases drug resistance by protecting FBXO21 mediated ubiquitination of P-glycoprotein". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4226.
Texto completoTsai, M. J., W. Osman, A. Elhance, J. Adair, L. Chafin, J. D. Londino y R. K. Mallampalli. "FBXO45 Targets IFNLR1 to Impair IFN-lambda Signaling During Influenza Infection". En American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3622.
Texto completoNelson, David E. y Heike Laman. "Abstract 2961: Spatiotemporal regulation of the SCF ubiquitin ligase component, Fbxo7". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-2961.
Texto completoKatayama, Kazuhiro, Kohji Noguchi, Junko Mitsuhashi y Yoshikazu Sugimoto. "Abstract 810: FBXO15 is an F-box protein in E3 ligase complex for P-glycoprotein". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-810.
Texto completoLu, Jianrong, Yue Jin, Anitha K. Shenoy, Hao Chen, Huacheng Luo, Lizi Wu y Kamal A. Mohammed. "Abstract 1425: FBXO11 suppresses epithelial plasticity and proliferation by ubiquitinating the Snail family of transcription factors". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1425.
Texto completoYan, Ying, Lepakshe Madduri, Nichole Brandquist, Chitra Palanivel, Sumin Zhou, Charles Enke y Michel Ouellette. "Abstract 1986: p53/FBXL20 axis negatively regulates the protein stability of PR55α, a PP2A regulatory subunit". En Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1986.
Texto completoRandle, Suzanne J., El Kahina Meziane, Mikhail Lomonosov y Heike Laman. "Abstract LB-189: Fbxo7 functions in the proliferation and maturation of hematopoietic cells". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-lb-189.
Texto completoXu, F., M. Ceng y W. Ouyang. "FBXO6 Regulates Antiviral Immunity Through Inhibition of ER-Stress Induced Apoptosis of Alveolar Macrophages". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3977.
Texto completoStankiewicz, Elzbieta, Xueying Mao, D. Chas Mangham, Lei Xu, Gabrielle Fisher, Bernard North, Henrik Moller et al. "Abstract 1614: Identification of FBXL4 as a bone metastasis-associated gene in prostate cancer". En Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1614.
Texto completoValverde, Alfonso García, Jordi Rosell, Daniel Pilco Janeta, Sergi Sayols, Claudia Valverde, Anna Esteve, Marta Gut et al. "Abstract 3767: FBXO32 ubiquitin ligase mediates apoptosis evasion and adaptation to KIT inhibition in gastrointestinal stromal tumor - GIST". En Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-3767.
Texto completo